Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16508703rdf:typepubmed:Citationlld:pubmed
pubmed-article:16508703lifeskim:mentionsumls-concept:C1622968lld:lifeskim
pubmed-article:16508703lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:16508703lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:16508703lifeskim:mentionsumls-concept:C1136102lld:lifeskim
pubmed-article:16508703lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:16508703pubmed:issue8lld:pubmed
pubmed-article:16508703pubmed:dateCreated2006-7-19lld:pubmed
pubmed-article:16508703pubmed:abstractTextThe majority of the neutralizing epitopes of papillomaviruses (PV) are conformation-specific and have not been fully characterised. Studies have, to date, been limited to a few HPV types only. We analysed the epitopes on the major capsid protein (L1) of Human papillomavirus (HPV) type 31 using monoclonal antibodies (MAbs) generated against HPV-31 virus-like particles (VLPs). The type-specific MAbs against HPV-31 were all found to be neutralizing and recognized conformation-dependent epitopes. Two other MAbs directed against a conformational epitope were found to be cross-reactive with other HPV types, and one of them was found to be cross-neutralizing. Cross-reactive antibodies were further investigated using wild-type HPV-16 L1 VLPs and two mutants. The results obtained suggested the existence of a cross-neutralizing conformational epitope at the N-terminal part of the FG loop of the major capsid protein, and the other four cross-reactive MAbs recognized epitopes also located at the N-terminal part of the FG loop.lld:pubmed
pubmed-article:16508703pubmed:languageenglld:pubmed
pubmed-article:16508703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:citationSubsetIMlld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16508703pubmed:statusMEDLINElld:pubmed
pubmed-article:16508703pubmed:monthAuglld:pubmed
pubmed-article:16508703pubmed:issn0304-8608lld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:CoursagetPPlld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:AlvarezEElld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:ClaverMMlld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:CarpentierGGlld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:TouzéAAlld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:FleuryM J JMJlld:pubmed
pubmed-article:16508703pubmed:authorpubmed-author:VautherotJ-FJ...lld:pubmed
pubmed-article:16508703pubmed:issnTypePrintlld:pubmed
pubmed-article:16508703pubmed:volume151lld:pubmed
pubmed-article:16508703pubmed:ownerNLMlld:pubmed
pubmed-article:16508703pubmed:authorsCompleteYlld:pubmed
pubmed-article:16508703pubmed:pagination1511-23lld:pubmed
pubmed-article:16508703pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:meshHeadingpubmed-meshheading:16508703...lld:pubmed
pubmed-article:16508703pubmed:year2006lld:pubmed
pubmed-article:16508703pubmed:articleTitleIdentification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.lld:pubmed
pubmed-article:16508703pubmed:affiliationINSERM U618, Université François Rabelais, Tours, France.lld:pubmed
pubmed-article:16508703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16508703pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16508703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16508703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16508703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16508703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16508703lld:pubmed